Inozyme Pharma, Inc. (INZY)

Inozyme Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.85	21.08	34.59	32.92	23.32	28.04
Short-Term Investments	58.93	92.01	154	94.95	88.49	119.66
Cash & Short-Term Investments	84.78	113.09	188.59	127.87	111.8	147.7
Cash Growth	-48.98%	-40.03%	47.49%	14.37%	-24.30%	213.37%
Other Receivables	-	0.47	0.39	0.12	0.06	0.16
Receivables	-	0.47	0.39	0.12	0.06	0.16
Prepaid Expenses	8.55	6.81	7.28	3.41	3.48	3.13
Restricted Cash	0.31	0.31	-	-	-	-
Total Current Assets	93.64	120.68	196.25	131.39	115.34	150.98
Property, Plant & Equipment	1.02	1.35	2.59	3.64	4.44	2.65
Long-Term Investments	-	-	-	-	-	12.2
Other Long-Term Assets	0.51	1.16	2.01	4.16	3.76	3.54
Total Assets	95.16	123.18	200.85	139.2	123.54	169.36
Accounts Payable	3.67	2.53	1.17	2.54	2.39	3.07
Accrued Expenses	12.74	15.95	12.61	11.36	8.51	6.63
Current Portion of Long-Term Debt	25.7	14.5	-	-	-	-
Current Portion of Leases	0.67	0.91	0.91	0.82	0.73	-
Other Current Liabilities	-	-	-	-	-	0.28
Total Current Liabilities	42.78	33.9	14.69	14.72	11.63	9.97
Long-Term Debt	20.59	31.46	44.77	4.14	-	-
Long-Term Leases	-	-	0.91	1.82	2.64	-
Other Long-Term Liabilities	-	-	-	0.12	-	1.29
Total Liabilities	63.37	65.36	60.37	20.8	14.27	11.26
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	447.79	445.71	426.36	333.36	256.95	249.18
Retained Earnings	-415.99	-387.95	-285.93	-214.76	-147.7	-91.08
Comprehensive Income & Other	-0.01	0.07	0.04	-0.21	0.02	0
Total Common Equity	31.8	57.83	140.48	118.39	109.27	158.1
Shareholders' Equity	31.8	57.83	140.48	118.39	109.27	158.1
Total Liabilities & Equity	95.16	123.18	200.85	139.2	123.54	169.36
Total Debt	46.95	46.87	46.59	6.78	3.37	-
Net Cash (Debt)	37.82	66.21	142	121.09	108.43	147.7
Net Cash Growth	-68.36%	-53.37%	17.27%	11.67%	-26.59%	213.37%
Net Cash Per Share	0.60	1.05	2.74	3.21	4.60	13.38
Filing Date Shares Outstanding	64.56	64.24	61.77	43.72	23.67	23.46
Total Common Shares Outstanding	64.47	64.24	61.77	40.39	23.67	23.38
Working Capital	50.86	86.78	181.56	116.68	103.71	141.01
Book Value Per Share	0.49	0.90	2.27	2.93	4.62	6.76
Tangible Book Value	31.8	57.83	140.48	118.39	109.27	158.1
Tangible Book Value Per Share	0.49	0.90	2.27	2.93	4.62	6.76
Machinery	-	1.77	1.72	1.62	1.29	0.88
Leasehold Improvements	-	2.17	2.16	2.13	2.1	2.1

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q